Home Crystal structure of poly[(μ-benzoato)-(μ-cis-4–hydroxy-D-proline)lithium], C12H14LiNO5
Article Open Access

Crystal structure of poly[(μ-benzoato)-(μ-cis-4–hydroxy-D-proline)lithium], C12H14LiNO5

  • Dejing Yin , Lingling Wang and Zhenbo Yuan ORCID logo EMAIL logo
Published/Copyright: September 6, 2023

Abstract

(C12H14LiNO5)n, orthorhombic, P212121 (no. 19), a = 5.1481(4) Å, b = 8.9342(7) Å, c = 25.733(2) Å, Z = 4, V = 1183.57(16) Å3, R gt(F) = 0.0539, wR ref(F 2) = 0.1478, T = 100 K.

CCDC no.: 2269079

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless needle
Size: 0.20 × 0.04 × 0.02 mm
Wavelength: Cu Kα radiation (1.54178 Å)
μ: 0.94 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω
θ max, completeness: 68.3°, 99 %
N(hkl)measured, N(hkl)unique, R int: 8,285, 2157, 0.100
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 1855
N(param)refined: 182
Programs: Bruker [1], Shelx [2, 3], Diamond [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
C1 0.0220 (9) 0.0208 (5) 0.57642 (15) 0.0213 (9)
C2 −0.1896 (9) 0.1001 (5) 0.55701 (17) 0.0255 (10)
H2 −0.285184 0.164557 0.579295 0.031*
C3 −0.2616 (10) 0.0855 (6) 0.50550 (18) 0.0314 (11)
H3 −0.404115 0.141536 0.492396 0.038*
C5 0.0808 (11) −0.0916 (6) 0.49202 (18) 0.0326 (11)
H5 0.170596 −0.159697 0.470086 0.039*
C4 −0.1263 (10) −0.0110 (6) 0.47272 (17) 0.0327 (11)
H4 −0.176232 −0.021155 0.437359 0.039*
C7 0.1048 (8) 0.0369 (4) 0.63252 (16) 0.0186 (8)
C6 0.1595 (10) −0.0737 (5) 0.54361 (17) 0.0263 (10)
H6 0.307055 −0.126285 0.55623 0.032*
C8 0.8006 (9) 0.4659 (4) 0.70540 (16) 0.0209 (9)
H8 0.928761 0.389686 0.717759 0.025*
C9 0.8433 (9) 0.4931 (4) 0.64694 (15) 0.0220 (9)
H9A 1.014035 0.453763 0.635675 0.026*
H9AB 0.70511 0.444642 0.626136 0.026*
C10 0.8326 (9) 0.6631 (4) 0.64121 (16) 0.0223 (9)
H10 0.923825 0.697883 0.609091 0.027*
C11 0.9694 (9) 0.7163 (5) 0.69026 (16) 0.0220 (9)
H11A 1.160143 0.705126 0.68731 0.026*
H11B 0.927141 0.822008 0.698058 0.026*
C12 0.5276 (8) 0.4148 (4) 0.72028 (15) 0.0187 (8)
Li1 0.5867 (16) 0.0985 (8) 0.6827 (3) 0.0249 (15)
N1 0.8595 (7) 0.6126 (4) 0.73080 (13) 0.0187 (8)
H7 0.712 (6) 0.645 (6) 0.7435 (19) 0.027 (14)*
H1 0.953 (7) 0.604 (5) 0.7591 (11) 0.010 (10)*
O1 0.3316 (6) −0.0048 (3) 0.64441 (11) 0.0227 (7)
O2 −0.0584 (6) 0.0897 (3) 0.66424 (10) 0.0216 (7)
O3 0.4585 (6) 0.2899 (3) 0.70252 (11) 0.0254 (7)
O4 0.3930 (6) 0.4975 (3) 0.74887 (10) 0.0203 (6)
O5 0.5652 (6) 0.7033 (3) 0.64091 (11) 0.0244 (7)
H5A 0.5500 (12) 0.806 (7) 0.638 (2) 0.037*

1 Source of material

Lithium hydroxide monohydrate (0.0419 g, 1 mmol), benzoic acid (0.1220 g, 1 mmol) and cis-4-hydroxy-D-proline (0.1311 g, 1 mmol) were dissolved in 2 mL of hot deionized water and then left to stand on a hot plate (70–80 °C) to allow slow evaporation of solvent until needle colorless crystals had emerged from solution.

2 Experimental details

The structure was solved and refined using the Bruker Shelxtl software package [2, 3]. All hydrogen atoms were placed in the calculated positions and constrained to ride on their parent atoms. The absolute structure determination succeeded as the derived Flack parameter is found to be near zero [0.0 (3) from 636 selected quotients] using Parsons’ method [5].

3 Comment

Lithium compounds play an important role in reducing manic episodes and suicidality for patients with bipolar disorder [6], [7], [8]. Compared to FDA approved lithium pharmaceuticals (lithium carbonate and lithium citrate), organic lithium salts are expected to improve the pharmacokinetic properties [9]. Therefore, organic lithium salts have been widely investigated for their good values of new drug development and market prospects [10]. Herein, we report a new salt-type cocrystal which contains three components, including lithium ion, the benzoate anion, and cis-4-hydroxy-D-proline as amino acid. In the structure of the title compound, each lithium ion was linked with four adjacent carboxylate moieties, two from benzoate and two from cis-4-hydroxy-D-proline molecules (Li–O distance: 1.884, 1.902, 1.890, 1.980 Å). The benzoato ligand is almost flat which is in agreement with the literature [11]. The hydroxyl group and protonated nitrogen atoms of cis-4-hydroxy-D-proline formed hydrogen bonds with carboxylate moieties, respectively (O−H···O: 2.873 Å, N+−H···O : 2.852, 2.896 Å).


Corresponding author: Zhenbo Yuan, Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi 214122, P.R. China, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by Jiangsu Planned Project for Postdoctoral Research Funds (2020Z383).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. Saint (Version 8.38A); Bruker AXS Inc: Madison, Wisconsin, USA, 2017.Search in Google Scholar

2. Sheldrick, G. M. SHELXTL – Integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Search in Google Scholar PubMed PubMed Central

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar PubMed PubMed Central

4. Brandenburg, K. DIAMOND. Visual Crystal Structure Information System. Ver. 3.2; Crystal Impact: Bonn, Germany, 2012.Search in Google Scholar

5. Parsons, S., Flack, H. D., Wagner, T. Use of intensity quotients and differences in absolute structure refinement. Acta Crystallogr. 2013, B69, 249–259. https://doi.org/10.1107/s2052519213010014.Search in Google Scholar PubMed PubMed Central

6. Thies-Flechtner, K., Müller-Oerlinghausen, B., Seibert, W., Walther, A., Greil, W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders-data from a randomized prospective trial. Pharmacopsychiatry 1996, 29, 103–107. https://doi.org/10.1055/s-2007–979553.10.1055/s-2007-979553Search in Google Scholar PubMed

7. Goodwin, F. K., Fireman, B., Simon, G. E., Hunkeler, E. M., Lee, J., Revicki, D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003, 290, 1467–1473. https://doi.org/10.1001/jama.290.11.1467.Search in Google Scholar PubMed

8. Cipriani, A., Hawton, K., Stockton, S., Geddes, J. R. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 2013, 346, f3646. https://doi.org/10.1136/bmj.f3646.Search in Google Scholar PubMed

9. Smith, A. J., Kim, S.-H., Duggirala, N. K., Jin, J., Wojtas, L., Ehrhart, J., Giunta, B., Tan, J., Zaworotko, M. J., Shytle, R. D. Improving lithium therapeutics by crystal engineering of novel ionic cocrystals. Mol. Pharm. 2013, 10, 4728–4738. https://doi.org/10.1021/mp400571a.Search in Google Scholar PubMed PubMed Central

10. Sanii, R., Andaloussi, Y. H., Patyk-Kaźmierczak, E., Zaworotko M. J. Polymorphism in ionic cocrystals comprising lithium salts and l-proline. Cryst. Growth Des. 2022, 22, 3786–3794. https://doi.org/10.1021/acs.cgd.2c00172.Search in Google Scholar PubMed PubMed Central

11. Fei, Y., Pengju, L., Libing, G., Dong, X. The crystal structure of bis(benzoato-κ2 O,O′)-(2,9-dimethyl-1,10-phenanthroline-κ2 N,N′)-copper(II), C28H22CuN2O4. Z. Kristallogr. N. Cryst. Struct. 2021, 236, 1219–1221.Search in Google Scholar

Received: 2023-06-19
Accepted: 2023-08-20
Published Online: 2023-09-06
Published in Print: 2023-12-15

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of bis(dimethylammonium) poly[(μ4-1,1′-(1,4-phenylenebis(methylene))bis(1H-pyrazole-3,5-dicarboxylato))-κ6O1, N2:O2:O3:O1′,N2′]nickel (II)], C22H26N6NiO8
  4. Hydrothermal synthesis and crystal structure of catena-poly[diaqua-bis(μ2-4-((pyridin-4-ylmethyl)amino)benzoato-κ2N:O)cobalt(II)] 4,4′-bipyridine – water (1/2/2)
  5. Crystal structure of (2S,3S,4S,5S, Z)-2,3,5,6-tetrakis(benzyloxy)-4-hydroxyhexanal oxime, C34H37NO6
  6. The crystal structure of hexakis(3-thiophenecarboxylato-κ2O,O″)-bis(1,10-phenanthroline-κ2N,N′) trimanganese(II), C54H34N4O12S6Mn3
  7. Crystal structure of catena-poly[(μ2-1,4-di(pyridin-4-yl)benzene-κ2N:N′)-(4-bromobenzoate-κ2O:O′)-(μ-2-bromobenzoate-κ2O,O′)nickel(II)] – water (2/1), C30H21Br2N2NiO4.5
  8. The crystal structure of poly[(μ3-1,3-phenylenedioxydiacetate-κ5O,O,O′,O″,O‴)-bis(4′-(4-(1H-imidazol-1-yl)phenyl)-4,2′:6′,4″-terpyridine-kN) cadmium(II)], C58H42CdN10O6
  9. The crystal structure of 5-chloro-6′-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3′-bipyridin]-1′-ium 4-methylbenzenesulfonate
  10. Crystal structure of poly[(μ-benzoato)-(μ-cis-4–hydroxy-D-proline)lithium], C12H14LiNO5
  11. The crystal structure of catena-poly[aqua-(4-iodopyridine-2,6-dicarboxylato-κ3N,O,O)-copper(II)] monohydrate, C7H6NO6ICu
  12. The crystal structure of catena-[diaqua-(4-acetylphenoxyacetato-κ2O,O)-bis(4-acetylphenoxyacetato-κ3O,O:O)-dihydrate-lanthanum(III)]–4,4′-bipyridine (2/1), C35H35NO14La
  13. The crystal structure of catena-poly[(4-iodopyridine-2,6-dicarboxylato-κ4 O,N,O′,O′′)(4-imidazol-1-yl-pyridine-κN)copper(II)], C15H9N4O4ICu
  14. Crystal structure of polybis(μ 4-3,5-dicarboxylatopyrazol-1-yl)-bis(N,N-dimethylformamide)tri-copper(II)–acetonitrile (1/2), C20H22Cu3N8O10
  15. Crystal structure of poly[(μ2-5-hydroxy-isophthalato-κ4O,O′:O″,O‴)-(μ2-1,5-bis(imidazol-2-methyl)pentane-κ2N:N′)cadmium(II)], C21H24CdN4O5
  16. The crystal structure of poly[bis(μ2-1,4-bi(1-imidazolyl)benzene-κ2N:N′)bis(μ2-4,4′-methylenebis(3-hydroxy-2-naphthoate)-κ2O:O′)cobalt(II)], C35H24CoN4O6
  17. The crystal structure of a cobalt-vanadium-oxido hydrate
  18. The crystal structure of catena-poly[(μ 2-2H-1,2,3-triazole-4,5-dicarboxylato-κ 2 O, O′)-(μ 2-1,3-bis((1H-imidazol-1-yl)methyl)benzene-κ 2 N,N′) zinc(II)], C18H15N7O4Zn
  19. Crystal structure of poly[diaqua-(bis(m2-1,4-bis(imidazol-1-ylmethyl)benzene)-κ2N,N′-manganese] dichloride, C28H32MnN8O2Cl2
  20. The crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino [3,2-a]isoquinolin-7-ium (E)-3-(4-nitrophenyl)acrylate pentahydrate, C29H34N2O13
  21. Crystal structure of poly[(μ6-ammoniotris(methylene))tris(hydrogen phosphonato)cadmium(II)], C3H10CdNO9P3
  22. Crystal structure of Zn2[(1,1′-(hexane-1,6-diyl)bis(3-(pyridin-3-yl)urea))·(H2O)2·(DMF)2·(SO4)2], C24H50N8O18S2Zn2
  23. The crystal structure of 2-anilino-1,4-naphthoquinone, C10H11NO2
  24. Crystal structure of (E)-2-(2-(4-(diethylamino)styryl)-1-ethyl-1,4-dihydroquinolin-4-yl) malononitrile, C26H26N4
  25. Crystal structure of ethyl 2-((2,6-dichloro-4-(cyanomethyl)phenyl) amino)benzoate, C17H14Cl2N2O2
  26. Synthesis and crystal structure of 2-(3-oxo-3-phenylpropyl)isoindoline-1,3-dione, C17H13NO3
  27. The crystal structure of bis(acetonitrile-κ1N)tetrakis(μ2-2,6-difluorobenzoato-κ2O:O′)rhodium(II) (Rh–Rh), C32H18F8O8N2Rh2
  28. The crystal structure of a new polymorph of 6-hydroxy-2-naphthoic acid, C11H8O3
  29. The crystal structure of [(8-carboxymethoxy-quinoline-2-carboxylate-κ4N,O,O,O)-2,2′-bipyridine-κ2N-copper(II)] tetrahydrate, C22H23N3O9Cu
  30. The crystal structure of ethyl 4-hydroxy-2-(4-methoxyphenyl)-5-oxo-1-(2-oxo-2H-chromen-6-yl)-2,5-dihydro-1H-pyrrole-3-carboxylate, C23H19NO7
  31. Crystal structure of 7-hydroxy-3,4-dihydronaphthalen-1(2H)-one, C10H10O2
  32. Crystal structure of bis(tetrapropylammonium) dodecacarbonyltetratelluridotetraferrate(2-), (Pr4N)2[Fe4Te4(CO)12]
  33. The crystal structure of poly[bis(μ2−3−aminopyridine−4−carboxylatoκ2N:O)Zinc(II)], [Zn(C6H5N2O2)2] n
  34. The crystal structure of methyl 5-nitro-2-(tosyloxy)benzoate, C15H13NO7S
  35. The crystal structure of 18-crown-6 ― tetraaqua-dichlorido-di-μ2-chloridodicopper(II) (2/1), C12H32O10Cu2Cl4
  36. Crystal structure of 6,6a,7,8,9,10-hexahydro-5H-pyrazino [2,3-e]pyrido[1,2-a]pyrazine, C10H14N4
  37. Crystal structure of catena-poly-{diaqua-bis[μ-(((4-chlorophenyl)sulfonyl)glycinato-κO)](μ2-4, 4′-bipyridine-κ2N:N′)cobalt(II)} dihydrate, C26H30Cl2CoN4O12S2
  38. Crystal structure of bis{N′-[1,3-diphenylprop-2-en-1-ylidene]-N-phenylcarbamohydrazonothioato}zinc(II), C44H36N6S2Zn
  39. Crystal structure of tetraaqua-bis(((4-chlorophenyl)sulfonyl)glycinato-κO)cobalt(II) dihydrate, C16H26Cl2CoN2O14S2
  40. Crystal structure of 2-(5-phenyl-1-(quinolin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenol, C24H19N3O
  41. Crystal structure of 2-((2-fluoro-4-(trifluoromethyl)phenyl)(hydroxy)methyl)-7-methoxy-3,4-dihydronaphthalen-1((2H))-one, C19H16F4O3
  42. Crystal structure of 2-amino-4-(2-fluoro-3-(trifluoromethyl)phenyl)-9-methoxy-1,4,5,6-tetrahydrobenzo[h]quinazolin-3-ium chloride, C20H18ClF4N3O
  43. Crystal structure of (2-phenylimino methylquinoline-κ 2 N,N′)-bis(1–phenylpyrazole-κ 2 C,N)-iridium(III) hexafluorophosphate, C34H26F6IrN6P
  44. Crystal structure of (3-hydroxy-4-methoxyphenyl)(pyrrolidin-1-yl)methanone, C12H15NO3
  45. The crystal structure of bis(trimethylsulfoxonium) catena-poly[µ2-hexabromido-indium(III)sodium(I)] C6H18O2S2NaInBr6
  46. Crystal structure of N-cyclopropyl-3-hydroxy-4-methoxybenzamide, C11H13NO3
  47. The crystal structure of (bis(benzimidazol-2-yl-methyl)amine-κ3N,N,N )-(dihydrogen L-malate-κ2O,O )copper(II) perchlorate dihydrate, CuC20H24ClN5O12
  48. Crystal structure of (1E,1′E)-4,4′-(9,9-diethyl-9H-fluorene-2,7-diyl)dibenzaldehyde dioxime, C31H28N2O2
  49. Crystal structure of diethyl 1,9-bis(4-fluorophenyl)-4,6-diphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta [b]pyridine-3,7(2H)-dicarboxylate, C40H36F2N2O4
  50. Crystal structure of bis(benzene-1 carboxylato-O 3,5-carboxyl-κ1O)-[(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)nickel(II) ─ benzene-1,3,5-tricarboxylic acid ─ water (1/2/4), C52H66N4NiO28
  51. Crystal structure of 1,4-dibromo-2,5-bis(2-methoxyethoxy)benzene-1,4-diol, C12H16Br2O4
  52. Crystal structure of dicarbonyl[N,N′-(1,2-dimethyl-1,2-ethanediylidene)bis[2,6-bis(1-methylethyl)benzenamine]-N,N′]nickel(0), C30H40N2NiO2
  53. Crystal structure of 1,4-dibromo-2,5-bis(prop-2-yn-1-yloxy)benzene, C12H8Br2O2
  54. Crystal structure of O-(3-(benzo[d]thiazol-2-yl)naphthalen-2-yl) O-phenyl carbonothioate, C24H15NO2S2
  55. The crystal structure of (E)-4-fluoro-N′-(1-(4-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2
  56. Crystal structure of (E)-1-(benzo[d]thiazol-2-yl)-N-(4,5-dihydropyren-2-yl)methanimine, C24H16N2S
  57. Crystal structure of 3-((4-bromophenyl)thio)-1H-indole, C14H10BrNS
  58. Synthesis and crystal structure of 1-((7-hydroxy-3-(4-hydroxy-3-nitrophenyl)-4-oxo-4H-chromen-8-yl)methyl)piperidin-1-ium-4-carboxylate monohydrate, C22H22N2O9
  59. Synthesis and crystal structure of (3E,5S,10S,13S,14S,17Z)-17-ethylidene-10,13-dimethylhexadecahydro-3H-cyclopenta[α]phenanthren-3-one O-(methacryloyl) oxime, C50H74N2O4
  60. Crystal structure of the hydrogen storage active phase La12Mg46LiMn
  61. The crystal structure of the salt: 4-((1,3-dioxoisoindolin-2-yl)carbamoyl)pyridine-1-ium 2-carboxybenzoate, C14H10N3O3·C8H5O4
  62. Crystal structure of (2-(2-pyridine)-benzimidazole-κ2 N,N′)-bis(1-phenylpyrazole-κ2 C,N)iridium(III) hexafluorophosphate, C30H22F6IrN7P
  63. Crystal structure of dichlorido-bis[2-(2,4-difluorophenyl)pyridine-κ1N]platinum(II), C22H14Cl2F4N2Pt
  64. Crystal structure of (5R,8R,9R,10R,12R,13R,14R, 17S,17Z)-2-((3-fluoropyridin-4-yl)methylene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H52FNO3
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2023-0289/html
Scroll to top button